After winning the first two trials over injuries allegedly caused by its Obtryx sling, Boston Scientific has been ordered to pay $73 million to a plaintiff in a Texas state court case. A Bloomberg story reports that this is the first award against this particular company because of a vaginal-mesh implant.
Boston Scientific was found liable for defectively designing its vaginal mesh sling. The plaintiff suffered from minor urine leakage when she received ...
continue reading...
A family in Texas harmed by Aruba Petroleum’s release of dangerous air pollutants from fracking wells received $2.95 million in damages in a recent Texas court decision. This is one of the first successful fracking lawsuits in the U.S. where the plaintiff has received significant compensation alleging a fracking company’s actions has led to detriment to their health.
In March 2011, the family filed a fracking lawsuit against eleven oil and gas production companies, including Aruba ...
continue reading...
A $100 million settlement with Merck & Co. has been finalized as 95 percent of claimants opted to receive compensation. The settlement regarding the company’s hormonal contraceptive, NuvaRing, was announced in February. There will be about 3,800 people that will receive compensation through the NuvaRing settlement.
The NuvaRing lawsuits alleged that Merck had downplayed the health risks connected to the contraceptive and did not adequately warn its users about the potential serious complications. ...
continue reading...
GlaxoSmithKline, a London-based pharmaceutical company, agreed to pay a $105 million settlement to 44 states and the District of Columbia. The company was allegedly unlawfully marketing Advair, its asthma drug, and two popular antidepressants.
The lawsuits claimed that GlaxoSmithKline was using off-label marketing and violated state consumer protection laws. Off-label marketing is when a company markets a drug for uses that are not approved by ...
continue reading...Boehringer Ingelheim Pharmaceuticals, Inc., manufacturer of Pradaxa, has agreed to pay $650 million to settle Pradaxa lawsuits filed on behalf of approximately 4,000 injured plaintiffs. Managing partner Ramon Lopez serves on the Plaintiffs Steering Committees both for the Illinois Multi District Litigation and the California State Coordinated Actions. Mr. Lopez played an important role in the pretrial and discovery proceedings that led to the settlement agreement, and helped to negotiate the settlement on behalf of ...
continue reading...
Pfizer Inc., manufacturer of Lipitor, Effexor, Zoloft and numerous other medications, has agreed to pay $325 million to resolve a decade-old lawsuit over Neurontin, a drug developed to treat epilepsy. Pfizer was accused of selling the drug without approval by the U.S. Food and Drug Administration and without medical support for its claimed benefits, in an attempt to maximize profits.
This is not ...
continue reading...
